Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[PTHrP-producing diffuse large B-cell lymphoma presenting with hypercalcemia at diagnosis]Chihiro Shirai, Makiko Mizuguchi, Tomoko Maruhashi, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 27, 2017
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of Cryptosporidium oocysts by intestinal biopsiesKumiko Kagawa, Hikaru Fujino, Hirokazu Miki, et al.International Journal of Hematology|January 22, 2024
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomibTomoko Maruhashi, Hirokazu Miki, Kimiko Sogabe, et al.Ejhaem|July 18, 2022
The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone diseaseHirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 12, 2018
Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndromeShingen Nakamura, Momoyo Azuma, Tomoko Maruhashi, et al.International Journal of Hematology|April 6, 2024
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acidYusuke Inoue, Asuka Oda, Yusaku Maeda, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy]Ryohei Sumitani, Takeshi Harada, Masafumi Nakamura, et al.International Journal of Hematology|April 11, 2023
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitorsEmiko Nakaue, Jumpei Teramachi, Hirofumi Tenshin, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2017
[Analysis of long-term survivors with cardiac AL amyloidosis]Kumiko Kagawa, Yusaku Maeda, Masahiro Oura, et al.Blood Advances|September 21, 2022
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinaseTakeshi Harada, Hiroto Ohguchi, Asuka Oda, et al.Pageof 2